Nektar Therapeutics (NASDAQ:NKTR) shares, rose in value on Friday, June 20, with the stock price down by -1.16% to the previous day’s close as strong demand from buyers drove the stock to $8.51.
Actively observing the price movement in the last trading, the stock closed the session at $8.61. Referring to stock’s 52-week performance, its high was $22.79, and the low was $6.48. On the whole, NKTR has fluctuated by -17.43% over the past month.
With the market capitalization of Nektar Therapeutics currently standing at about $105.58 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that NKTR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of NKTR currently trading nearly -14.43% and -14.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.04, while the 7-day volatility ratio is showing 5.52% which for the 30-day chart, stands at 9.14%. Furthermore, Nektar Therapeutics (NKTR)’s beta value is 0.56, and its average true range (ATR) is 1.22.
A comparison of Nektar Therapeutics (NKTR) with its peers suggests the former has fared considerably weaker in the market. NKTR showed an intraday change of -1.16% in last session, and over the past year, it shrunk by -51.51%%.
Data on historical trading for Nektar Therapeutics (NASDAQ:NKTR) indicates that the trading volumes over the past 3 months, they’ve averaged 211.59K. According to company’s latest data on outstanding shares, there are 12.41 million shares outstanding.
The stock has fallen by -39.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NKTR stock heading into the next quarter.
